Lista de obras - Michael Jeltsch - Dominio Público Uruguay

A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development.

artículo científico publicado en 2013

Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle

artículo científico publicado en 2009

Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes

artículo científico publicado en 2002

Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels.

artículo científico publicado en 2018

CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation

artículo científico publicado en 2014

Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development

scientific journal article

Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.

artículo científico publicado en 2012

Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins

artículo científico publicado en 2007

Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitis.

artículo científico publicado en 2005

Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization

artículo científico publicado en 2010

Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1

artículo científico publicado en 2017

Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein

artículo científico publicado en 2007

Factors regulating the substrate specificity of cytosolic phospholipase A2-alpha in vitro.

artículo científico publicado en 2016

Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain.

artículo científico publicado en 2015

Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis

artículo científico publicado en 2016

Functional interaction of VEGF-C and VEGF-D with neuropilin receptors

artículo científico publicado en 2006

Genesis and pathogenesis of lymphatic vessels

artículo científico publicado en 2003

Genomic organization of human and mouse genes for vascular endothelial growth factor C.

artículo científico publicado en 1997

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

artículo científico publicado en 1997

Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function

artículo científico publicado en 2003

Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts.

artículo científico publicado en 2015

KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D.

artículo científico publicado en 2019

Key molecules in lymphatic development, function, and identification.

artículo científico publicado en 2018

Lymphatic Vessels in Regenerative Medicine and Tissue Engineering

artículo científico publicado en 2016

Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy

artículo científico publicado en 2008

Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation.

artículo científico publicado en 2005

Proteolytic processing regulates receptor specificity and activity of VEGF-C ⬇️

artículo científico publicado el 1 de julio de 1997

Receptor tyrosine kinase-mediated angiogenesis

artículo científico publicado en 2013

Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium

artículo científico publicado en 2008

Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation

artículo científico publicado en 2013

Structural determinants of growth factor binding and specificity by VEGF receptor 2

artículo científico publicado en 2010

Structural determinants of vascular endothelial growth factor-D receptor binding and specificity

artículo científico publicado en 2011

Substrate efflux propensity is the key determinant of Ca2+-independent phospholipase A-β (iPLAβ)-mediated glycerophospholipid hydrolysis

artículo científico publicado en 2015

Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis

artículo científico publicado en 2010

The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.

artículo científico publicado en 2013

The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis

artículo científico publicado en 2008

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

artículo científico publicado en 2003

Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels

artículo científico publicado en 2005

Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity

artículo científico publicado en 1998

Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns

artículo científico publicado en 2006

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

artículo científico publicado en 2004

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

artículo científico publicado en 1998

Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation

artículo científico publicado en 2010

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

artículo científico publicado en 2001

Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis

artículo científico publicado en 2013

Vascular endothelial growth factors VEGF-B and VEGF-C ⬇️

artículo científico publicado el 1 de noviembre de 1997

Lista de obras de Michael Jeltsch

A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development.

Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle

Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes

Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels.

CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation

Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development

Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.

Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins

Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitis.

Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization

Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1

Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein

Factors regulating the substrate specificity of cytosolic phospholipase A2-alpha in vitro.

Functional Dissection of the CCBE1 Protein: A Crucial Requirement for the Collagen Repeat Domain.

Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis

Functional interaction of VEGF-C and VEGF-D with neuropilin receptors

Genesis and pathogenesis of lymphatic vessels

Genomic organization of human and mouse genes for vascular endothelial growth factor C.

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function

Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts.

KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D.

Key molecules in lymphatic development, function, and identification.

Lymphatic Vessels in Regenerative Medicine and Tissue Engineering

Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy

Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation.

Proteolytic processing regulates receptor specificity and activity of VEGF-C ⬇️

Receptor tyrosine kinase-mediated angiogenesis

Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium

Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation

Structural determinants of growth factor binding and specificity by VEGF receptor 2

Structural determinants of vascular endothelial growth factor-D receptor binding and specificity

Substrate efflux propensity is the key determinant of Ca2+-independent phospholipase A-β (iPLAβ)-mediated glycerophospholipid hydrolysis

Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis

The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.

The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels

Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity

Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis

Vascular endothelial growth factors VEGF-B and VEGF-C ⬇️